9 December 2019 ORYZON presents new efficacy data from its Phase II trial ALICE investigating iadademstat in AML
3 October 2019 ORYZON Presents New Positive REIMAGINE Efficacy Data of Vafidemstat in the Treatment of Aggression
30 September 2019 ORYZON presents positive efficacy results on iadademstat in ED-SCLC patients at ESMO-2019